Global Anticoagulant Market 2017-2021

Global Anticoagulant Market 2017-2021

About Anticoagulant Market

Anticoagulant prevent clot formations or the enlargement of existing clots in the arteries or veins. Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K antagonists; DTIs; and factor Xa inhibitors are among the anticoagulant that are available in the market. They are used for indications such as heart attack, stroke, deep venous thrombosis (DVT), pulmonary embolism (PE), surgery, angina, dialysis, atrial fibrillation (AF), thrombocytopenia, and myocardial infarction. Bayer HealthCare, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Johnson & Johnson, and Sanofi are some of the top vendors in the market.

Technavio’s analysts forecast the global anticoagulant market to grow at a CAGR of 7.42% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global anticoagulant market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded and generics drugs used to treat coagulation disorders.

The market is divided into the following segments based on geography:

  • Americas
  • EMEA
  • APAC
Technavio's report, Global Anticoagulant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key vendors
  • Bayer HealthCare
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Daiichi Sankyo
  • Johnson & Johnson
  • Sanofi
Other prominent vendors
  • Abbott Vascular
  • Abiomed
  • AtriCure
  • Biosensors International
  • Biotronik
  • BioVentrix
  • C. R. Bard
Market driver
  • Increasing demand for NOACs
  • For a full, detailed list, view our report
Market challenge
  • Increasing cost of NOACs
  • For a full, detailed list, view our report
Market trend
  • Strategic alliance
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

  • Executive summary
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Disease overview
    • Table Process of blood coagulation
    • Table Mechanism of action (MoA) of anticoagulant
    • Table Key customer segments of global anticoagulant market
  • Pipeline analysis
    • Table Pipeline analysis 2016
    • Table Key pipeline molecules
  • Market landscape
    • Market overview
      • Table Global anticoagulant market overview
      • Table Global anticoagulant market 2016-2021 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by ROA
    • Table Segmentation of anticoagulant market based on ROA
    • Table Market share of anticoagulant based on ROA 2016
    • Oral anticoagulants
    • Injectable anticoagulants
      • Table Types of heparin
  • Market segmentation by drug class
    • Table Segmentation of anticoagulant market based on drug class
    • Table Market share of anticoagulant based on drug class 2016
    • Factor Xa inhibitors
      • Table Types of factor Xa inhibitors based on MOA
      • Table Factor Xa inhibitors in global anticoagulant market 2016-2021 ($ billions)
    • DTIs
      • Table Types of DTIs based on MOA
      • Table DTIs in global anticoagulant market 2016-2021 ($ billions)
    • Heparin
      • Table Global heparin market 2016-2021 ($ billions)
    • Vitamin K antagonists
      • Table Global vitamin K antagonists market in 2016-2021 ($ billions)
  • Market segmentation by application
    • Table Market segmentation by application
    • DVT
    • PE
    • AF
    • Others
      • Table Market segmentation of anticoagulant based on application
  • Geographical segmentation
    • Global anticoagulant market in Americas
      • Table Anticoagulant market in Americas 2016-2021 ($ billions)
    • Anticoagulant market in EMEA
      • Table Anticoagulant market in EMEA 2016-2021 ($ billions)
    • Anticoagulant market in APAC
      • Table Anticoagulant market in APAC 2016-2021 ($ billions)
  • Market drivers
    • Increasing demand for NOACs
    • Growing prevalence of coagulation disorders
    • Increase in hip and knee surgeries
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Increasing cost of NOACs
    • Lack of antidotes in the market for NOACs
    • Patent expiry: a threat to market
      • Table Patents to expire over forecast period
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Strategic alliance
    • Increasing focus toward emerging economies
    • Patient assistance programs
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global anticoagulant market 2016
      • Table Competitive analysis of global anticoagulant market
      • Table Market share analysis 2016
      • Table Competitive landscape analysis 2016
    • Other prominent vendors
  • Key vendor analysis
    • Bayer HealthCare
      • Table Bayer HealthCare: Key highlights
      • Table Bayer HealthCare: Strength assessment
      • Table Bayer HealthCare: Strategy assessment
      • Table Bayer HealthCare: Opportunity assessment
      • Table Bayer HealthCare: YoY revenue and growth rate of XARELTO 2013-2015 ($ billions)
    • Boehringer Ingelheim
      • Table Boehringer Ingelheim: Key highlights
      • Table Boehringer Ingelheim: Strength assessment
      • Table Boehringer Ingelheim: Strategy assessment
      • Table Boehringer Ingelheim: Opportunity assessment
      • Table Boehringer Ingelheim: YoY revenue and growth rate of PRADAXA (global) 2013- 2015 ($ billions)
    • Bristol-Myers Squibb
      • Table Bristol-Myers Squibb: Highlights
      • Table Bristol-Myers Squibb: Strength assessment
      • Table Bristol-Myers Squibb: Strategy assessment
      • Table Bristol-Myers Squibb: Opportunity assessment
      • Table Bristol-Myers Squibb: YoY revenue and growth rate of ELIQUIS (global) 2013-2015 ($ millions)
      • Table Bristol-Myers Squibb: Geographic segmentation of ELIQUIS 2015
    • Daiichi Sankyo
      • Table Daiichi Sankyo: Key highlights
      • Table Daiichi Sankyo: Strength assessment
      • Table Daiichi Sankyo: Strategy assessment
      • Table Daiichi Sankyo: Opportunity assessment
    • Johnson & Johnson
      • Table Johnson & Johnson: Strength assessment
      • Table Johnson & Johnson: Strategy assessment
      • Table Johnson & Johnson: Opportunity assessment
    • Sanofi
      • Table Sanofi: Key highlights
      • Table Sanofi: Strength assessment
      • Table Sanofi: Strategy assessment
      • Table Sanofi: Opportunity assessment
      • Table Sanofi: YoY revenue and growth rate of LOVENOX (global) 2013-2015 ($ billions)
      • Table Sanofi: Geographical segmentation of LOVENOX 2016
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook